A case of hepatitis B virus-infected patient with bevacizumab-related severe intratumor hemorrhage of large hepatocellular carcinoma (HCC)-Reference-Cited by-同舟云学术

A case of hepatitis B virus-infected patient with bevacizumab-related severe intratumor hemorrhage of large hepatocellular carcinoma (HCC)

Published:2023-08-01 Issue:8 Volume:64 Page:382-392
ISSN:0451-4203
Container-title:Kanzo
language:en
Short-container-title:Acta hepatologica Japonica

Author:

Matsumoto Moe¹,Noritake Hidenao¹,Yamashita Maho¹,Hanaoka Tomohiko¹,Umemura Masahiro¹,Kitsugi Kensuke¹,Takatori Shingo¹,Ohta Kazuyoshi¹,Ito Jun¹,Chida Takeshi²,Kawata Kazuhito¹

Affiliation:

1. Division of Hepatology, Department of Internal Medicine, Hamamatsu University School of Medicine

2. Department of Regional Medical Care Support, Hamamatsu University School of Medicine

Publisher

Japan Society of Hepatology

Subject

Hepatology

Link

https://www.jstage.jst.go.jp/article/kanzo/64/8/64_382/_pdf

Reference41 articles.

1. 1) Schwabe RF, Wiley JW, Bruix J, et al. Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma. Gastroenterology 2016; 150: 835-853 doi: 10.1053/j.gastro.2015.12.041

2. 2) RS F, S Q, M I, et al. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma. N Engl J Med 2020; 382: 1894-1905 doi: 10.1056/NEJMOA1915745

3. 3) Reig M, Forner A, Rimola J, et al. BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update. J Hepatol 2022; 76: 681-693 doi: 10.1016/j.jhep.2021.11.018

4. 4) Tanaka T, Hiraoka A, Tada T, et al. Therapeutic efficacy of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma in patients with Child-Pugh class A or B liver function in real-world clinical practice. Hepatol Res May 2022 doi: 10.1111/HEPR.13797

5. 5) Hiraoka A, Kumada T, Tada T, et al. Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experience. Cancer Rep 2022; 5: e1464 doi: 10.1002/CNR2.1464

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fatal intratumoral hemorrhage in a patient with hepatocellular carcinoma following successful treatment with atezolizumab/bevacizumab: A case report;World Journal of Clinical Cases;2024-08-06

2. Atezolizumab/bevacizumab;Reactions Weekly;2024-06-22